SAMSUNG PHARMACEUTICAL.CO.,Ltd.
001360 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001360007
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단4길 10 -, 화성시
- Website:
- http://www.sspharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-25 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 12.2 KB | ||
| 2025-08-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 63.8 KB | ||
| 2025-08-21 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 5.8 KB | ||
| 2025-08-20 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 134.9 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.1 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 916.3 KB | ||
| 2025-08-08 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 67.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 896.6 KB | ||
| 2025-03-27 00:00 |
AGM Information
정기주주총회결과 (제 71기)
|
Korean | 22.5 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 11.9 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 495.1 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 9.2 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 120.2 KB | ||
| 2025-03-12 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 83.1 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.4 KB |
Automate Your Workflow. Get a real-time feed of all SAMSUNG PHARMACEUTICAL.CO.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and manufactures products for life science research and clinical diagnostic markets.
United States of America
BIO
United States of America
BIO
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden
BIOSGN
Sweden
BIOSGN
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea
086820
South Korea
086820
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France
ALBIO
France
ALBIO
Develops reagents and instruments for life sciences research and clinical diagnostic markets.
United States of America
TECH
United States of America
TECH
Develops biotech health supplements, animal feed additives, and functional cosmetics.
South Korea
289170
South Korea
289170
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Germany
BIO3
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Slovakia
BSL
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
Poland
BIO
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
United Kingdom
BVXP